Molecular Partners AG
MOLN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001745114
No open-market purchases or sales by Molecular Partners AG insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Molecular Partners AG changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 6 | 7 | +1 |
| Shares | 930.3K | 929.5K | −814 (−0.1%) |
| Value | $5.60M | $5.73M | +$129.3K (+2.3%) |
New holders (1)
Institutions that held Molecular Partners AG at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rhumbline Advisers | 269 | $1.64K | 0.00% |
Sold out (0)
Institutions that held Molecular Partners AG at the end of Q1 2023 and filed for Q2 2023 without it.
None.